An interdisciplinary team of UCF researchers is creating a single low-cost test to detect HIV & Hepatitis B & C simultaneously, that may be used in resource-limited settings. With quicker & more ...
DUBLIN, Ireland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, ...
Accurate monitoring of CD4 + T cell counts is vital for evaluating immune health and guiding treatment in people living with Human Immunodeficiency Virus (HIV). Yet conventional tools like flow ...
DUBLIN, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...
- TrinScreen HIV order signals renewed strength in global HIV testing market - Company also reports a key milestone of Adjusted EBITDA 1 positive operations in Q3 2025 and expects to achieve strong ...
A newly developed microfluidic biosensor promises to reshape how CD4+ T cells — key indicators of immune function in Human Immunodeficiency Virus (HIV) patients — are detected. By integrating ...
Colexa Biosensor Limited, subsidiary of Codix Group, has been licensed to package World Health Organisation (WHO) Prequalified Rapid Diagnostic Test (RDT) kit in Nigeria. This followed Change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback